New self-expanding transcatheter aortic valve device for transfemoral implantation - Early results of the first-in-Asia implantation of the ACURATE Neo/TF™ system

Circulation Journal

Volumn 79, Issue 5, 2015, Pages 1037-1043

  Maeda, Koichi ^a   Kuratani, Toru ^a   Torikai, Kei ^a   Mizote, Isamu ^a   Ichibori, Yasuhiro ^a   Onishi, Toshinari ^a   Nakatani, Satoshi ^a   Sakata, Yasushi ^a   Toda, Koichi ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aortic stenosis; Japanese; Valvular disease

Indexed keywords

AGED; AORTA VALVE; AORTOGRAPHY; ARTICLE; BIOPROSTHESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONVERSION TO OPEN SURGERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC CATHETER; ECHOCARDIOGRAPHY; EUROSCORE; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE PROSTHESIS; HUMAN; KIDNEY FAILURE; MALE; MORTALITY; PACEMAKER IMPLANTATION; SELF EXPANDING STENT; TA STENOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; AORTIC VALVE STENOSIS; CLINICAL TRIAL; DEVICES; HEART VALVE REPLACEMENT; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE;

EID: 84928492215     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1110     Document Type: Article

References (20)

1. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695.
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-1704.
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
5. Singh IM, Shishehbor MH, Christofferson RD, Tuzcu EM, Kapadia SR. Percutaneous treatment of aortic valve stenosis. Cleve Clin J Med 2008; 75: 805-812.
6. Chiam PT, Ruiz CE. Percutaneous transcatheter aortic valve implantation: Evolution of the technology. Am Heart J 2009; 157: 229-242.
7. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012; 60: 1438-1454.
8. Grube E, Sinning JM, Vahanian A. The year in cardiology 2013: Valvular heart disease (focus on catheter-based interventions). Eur Heart J 2014; 35: 490-495.
9. Maeda K, Kuratani T, Mizote I, Shimamura K, Takeda Y, Torikai K, et al. Early experiences of transcatheter aortic valve replacement in Japan. Circ J 2013; 77: 359-362.
10. Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, et al. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J 2014; 78: 1083-1090.
11. Kempfert J, Treede H, Rastan AJ, Schonburg M, Thielmann M, Sorg S, et al. Transapical aortic valve implantation using a new selfexpanding bioprosthesis (Acurate TA): 6-month outcomes. Eur J Cardiothorac Surg 2013; 43: 52-56.
12. Webb JG, Pasupati S, Humphries K, Thompson C, Altwagg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763.
13. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding corevalve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76.
14. De Jaegere PP, Piazza N, Galema TW, Otten A, Soliman OI, Van Dalen BM, et al. Early echocardiographic evaluation following percutaneous implantation with the self-expanding Corevalve Revalving system aortic valve bioprosthesis. EuroIntervention 2008; 4: 351-357.
15. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, et al. Transapical transcatheter aortic valve implantation using the JenaValveTM system: Acute and 30-day results of the Multicentre CE-Mark Study. Eur J Cardiothorac Surg 2012; 41: e131-e138, doi:10.1093/ejcts/ezs129.
16. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) Corevalve Revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE Mark approval. EuroIntervention 2008; 4: 242-249.
17. Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011; 57: 1650-1657.
18. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, et al. Transcatheter aortic valve implantation: First results from a multicentre real-world registry. Eur Heart J 2011; 32: 198-204.
19. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, et al. Transcatheter aortic valve implantation: Early results of the FRANCE (French Aortic National Corevalve and Edwards) Registry. Eur Heart J 2011; 32: 191-197.
20. Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: What is the incidence and are there any predicting factors? Interact Cardiovasc Thorac Surg 2011; 12: 243-253.